ECHA Board of Appeal | Germany LANXESS Deutschland GmbH, Schirm GmbH | 25 February 2021 | Assessment error of Diuron


Your substances

None

This news contains references also to other Substances


Subject matter: A decision taken by the European Chemicals Agency pursuant to Article 46(1) of the REACH Regulation

Remedy sought by the Appellants

On 26 October 2020, the Agency adopted the Contested Decision requesting the Appellants to submit information on a larval amphibian growth and development assay (the ‘LAGDA’) according to OECD test guideline 241 using African clawed frog (Xenopus laevis), including measurements of plasma vitellogenin. The study was requested to clarify concerns about the potential endocrine disrupting properties of diuron in the environment.

The Appellants request the Board of Appeal to annul the Contested Decision.

The Appellants also request the Board of Appeal to order the Agency to refund the appeal fee.

Link to the  ECHA Board of Appeal | Germany LANXESS Deutschland GmbH, Schirm GmbH | Assessment error of Diuron
                   

Related News

Loading...